Tags

Type your tag names separated by a space and hit enter

Cost-utility analysis of cataract surgery in the second eye.
Ophthalmology. 2003 Dec; 110(12):2310-7.O

Abstract

OBJECTIVE

To perform a reference case cost-utility analysis of second-eye cataract surgery by using the current literature on cataract outcomes and complications.

DESIGN

Computer-based econometric modeling.

METHODS

Visual acuity data of patients treated and observed over a 4-month postoperative period were obtained from the U.S. National Cataract Patient Outcomes Research Team report. The results from this prospective study were combined with those of other studies that investigated the complication rates of cataract surgery to complete the cohort of patients and outcomes. These synthesized data were incorporated with time trade-off utility values, which accounted for prior successful cataract surgery in the fellow eye. Cost-utility determinations were made with decision analysis, and present value modeling was used to account for the time value of money and health state consequences.

MAIN OUTCOME MEASURES

The number of quality-adjusted life-years (QALYs) gained was calculated for the study group undergoing second-eye cataract surgery, assuming that the postoperative vision in the second eye was equivalent to the vision in the first eye after surgery (20/27). This was divided into the cost of the procedure to find the number of year 2001 nominal U.S. dollars spent per QALY gained.

RESULTS

Second-eye cataract surgery, as compared with unilateral pseudophakia, resulted in a mean gain of 1.31 undiscounted QALYs per patient treated. A 3% annual discount rate, dependent on the duration of benefit, was used, yielding 0.92 discounted QALYs gained over a 12-year life expectancy. The mean discounted cost of treatment for each patient totaled 2509 US dollars. The cost divided by the QALYs gained (benefit) resulted in 2727 US dollars per QALY gained for this procedure. Sensitivity analysis varying costs and utility values revealed a range from 2045 US dollars to 3649 US dollars per QALY gained.

CONCLUSIONS

Second-eye cataract surgery is an extremely cost-effective procedure when compared with other interventions across medical specialties. The cost-effectiveness of second-eye surgery diminishes only slightly from the 2023 US dollars per QALY gained from first-eye cataract surgery. This suggests that patients with good vision in one eye and visual loss from cataract in the fellow eye derive substantial benefit from cataract extraction.

Authors+Show Affiliations

Center for Evidence-Based Health Care Economics, Wills Eye Hospital, Jefferson Medical College, Philadelphia, Pennsylvania, USA. bgbusbee@yahoo.comNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

14644712

Citation

Busbee, Brandon G., et al. "Cost-utility Analysis of Cataract Surgery in the Second Eye." Ophthalmology, vol. 110, no. 12, 2003, pp. 2310-7.
Busbee BG, Brown MM, Brown GC, et al. Cost-utility analysis of cataract surgery in the second eye. Ophthalmology. 2003;110(12):2310-7.
Busbee, B. G., Brown, M. M., Brown, G. C., & Sharma, S. (2003). Cost-utility analysis of cataract surgery in the second eye. Ophthalmology, 110(12), 2310-7.
Busbee BG, et al. Cost-utility Analysis of Cataract Surgery in the Second Eye. Ophthalmology. 2003;110(12):2310-7. PubMed PMID: 14644712.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Cost-utility analysis of cataract surgery in the second eye. AU - Busbee,Brandon G, AU - Brown,Melissa M, AU - Brown,Gary C, AU - Sharma,Sanjay, PY - 2003/12/3/pubmed PY - 2003/12/19/medline PY - 2003/12/3/entrez SP - 2310 EP - 7 JF - Ophthalmology JO - Ophthalmology VL - 110 IS - 12 N2 - OBJECTIVE: To perform a reference case cost-utility analysis of second-eye cataract surgery by using the current literature on cataract outcomes and complications. DESIGN: Computer-based econometric modeling. METHODS: Visual acuity data of patients treated and observed over a 4-month postoperative period were obtained from the U.S. National Cataract Patient Outcomes Research Team report. The results from this prospective study were combined with those of other studies that investigated the complication rates of cataract surgery to complete the cohort of patients and outcomes. These synthesized data were incorporated with time trade-off utility values, which accounted for prior successful cataract surgery in the fellow eye. Cost-utility determinations were made with decision analysis, and present value modeling was used to account for the time value of money and health state consequences. MAIN OUTCOME MEASURES: The number of quality-adjusted life-years (QALYs) gained was calculated for the study group undergoing second-eye cataract surgery, assuming that the postoperative vision in the second eye was equivalent to the vision in the first eye after surgery (20/27). This was divided into the cost of the procedure to find the number of year 2001 nominal U.S. dollars spent per QALY gained. RESULTS: Second-eye cataract surgery, as compared with unilateral pseudophakia, resulted in a mean gain of 1.31 undiscounted QALYs per patient treated. A 3% annual discount rate, dependent on the duration of benefit, was used, yielding 0.92 discounted QALYs gained over a 12-year life expectancy. The mean discounted cost of treatment for each patient totaled 2509 US dollars. The cost divided by the QALYs gained (benefit) resulted in 2727 US dollars per QALY gained for this procedure. Sensitivity analysis varying costs and utility values revealed a range from 2045 US dollars to 3649 US dollars per QALY gained. CONCLUSIONS: Second-eye cataract surgery is an extremely cost-effective procedure when compared with other interventions across medical specialties. The cost-effectiveness of second-eye surgery diminishes only slightly from the 2023 US dollars per QALY gained from first-eye cataract surgery. This suggests that patients with good vision in one eye and visual loss from cataract in the fellow eye derive substantial benefit from cataract extraction. SN - 0161-6420 UR - https://www.unboundmedicine.com/medline/citation/14644712/Cost_utility_analysis_of_cataract_surgery_in_the_second_eye_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0161-6420(03)00796-6 DB - PRIME DP - Unbound Medicine ER -